APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vaccine Testing Service Market Outlook and Growth Opportunities 2026

11 April 2026Not stated

Choose your research edition.

Industry ResearchVaccine Testing Service Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Testing Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Vaccine Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Testing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Vaccine Testing Service Market Analysis and Forecast 2026-2032255 pages · $4,950 USD

Market perspective

The global Vaccine Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vaccine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaccine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vaccine Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vaccine Testing Service market include RSSL, Labcorp Drug Development, Charles River Laboratories, PPD, WuXi Biologics, Valneva, IQVIA Laboratories Vaccines, Minaris Advanced Testing and IntoxLab, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Vaccine Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccine Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccine Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Vaccine Testing Service market.

Vaccine Testing Service Segment by Company

RSSL

Labcorp Drug Development

Charles River Laboratories

PPD

WuXi Biologics

Valneva

IQVIA Laboratories Vaccines

Minaris Advanced Testing

IntoxLab

Creative Diagnostics

Vaccine Testing Service Segment by Type

Physical and Chemical Testing

Microbial Detection

Immunological Testing

Others

Vaccine Testing Service Segment by Application

Inactivated Vaccine

Subunit Vaccine

Toxoid Vaccine

mRNA Vaccine

Viral Vector Vaccine

Others

Vaccine Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vaccine Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Vaccine Testing Service key companies, revenue, market share, and recent developments.

3. To split the Vaccine Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Vaccine Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vaccine Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Vaccine Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaccine Testing Service industry.

Chapter 3: Detailed analysis of Vaccine Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Vaccine Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Vaccine Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vaccine Testing Service Industry Trends Table 2. Vaccine Testing Service Industry Drivers Table 3. Vaccine Testing Service Industry Opportunities and Challenges Table 4. Vaccine Testing Service Industry Restraints Table 5. Global Vaccine Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vaccine Testing Service Revenue Share by Company (2021-2026) Table 7. Global Vaccine Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Vaccine Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global Vaccine Testing Service Company, Product Type & Application Table 10. Global Vaccine Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Vaccine Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Physical and Chemical Testing Table 15. Significant Companies of Microbial Detection Table 16. Significant Companies of Immunological Testing Table 17. Significant Companies of Others Table 18. Global Vaccine Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Vaccine Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Vaccine Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Vaccine Testing Service Sales Value Share by Type (2021-2026) Table 22. Global Vaccine Testing Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Inactivated Vaccine Table 24. Significant Companies of Subunit Vaccine Table 25. Significant Companies of Toxoid Vaccine Table 26. Significant Companies of mRNA Vaccine Table 27. Significant Companies of Viral Vector Vaccine Table 28. Significant Companies of Others Table 29. Global Vaccine Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Vaccine Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Vaccine Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Vaccine Testing Service Sales Value Share by Application (2021-2026) Table 33. Global Vaccine Testing Service Sales Value Share by Application (2027-2032) Table 34. Global Vaccine Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Vaccine Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Vaccine Testing Service Sales Value Share by Region (2021-2026) Table 37. Global Vaccine Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Vaccine Testing Service Sales Value Share by Region (2027-2032) Table 39. Global Vaccine Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Vaccine Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Vaccine Testing Service Sales Value Market Share by Country (2021-2026) Table 42. Global Vaccine Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Vaccine Testing Service Sales Value Market Share by Country (2027-2032) Table 44. RSSL Company Information Table 45. RSSL Business Overview Table 46. RSSL Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. RSSL Vaccine Testing Service Product Portfolio Table 48. RSSL Recent Development Table 49. Labcorp Drug Development Company Information Table 50. Labcorp Drug Development Business Overview Table 51. Labcorp Drug Development Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Labcorp Drug Development Vaccine Testing Service Product Portfolio Table 53. Labcorp Drug Development Recent Development Table 54. Charles River Laboratories Company Information Table 55. Charles River Laboratories Business Overview Table 56. Charles River Laboratories Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Charles River Laboratories Vaccine Testing Service Product Portfolio Table 58. Charles River Laboratories Recent Development Table 59. PPD Company Information Table 60. PPD Business Overview Table 61. PPD Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. PPD Vaccine Testing Service Product Portfolio Table 63. PPD Recent Development Table 64. WuXi Biologics Company Information Table 65. WuXi Biologics Business Overview Table 66. WuXi Biologics Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. WuXi Biologics Vaccine Testing Service Product Portfolio Table 68. WuXi Biologics Recent Development Table 69. Valneva Company Information Table 70. Valneva Business Overview Table 71. Valneva Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Valneva Vaccine Testing Service Product Portfolio Table 73. Valneva Recent Development Table 74. IQVIA Laboratories Vaccines Company Information Table 75. IQVIA Laboratories Vaccines Business Overview Table 76. IQVIA Laboratories Vaccines Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. IQVIA Laboratories Vaccines Vaccine Testing Service Product Portfolio Table 78. IQVIA Laboratories Vaccines Recent Development Table 79. Minaris Advanced Testing Company Information Table 80. Minaris Advanced Testing Business Overview Table 81. Minaris Advanced Testing Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Minaris Advanced Testing Vaccine Testing Service Product Portfolio Table 83. Minaris Advanced Testing Recent Development Table 84. IntoxLab Company Information Table 85. IntoxLab Business Overview Table 86. IntoxLab Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. IntoxLab Vaccine Testing Service Product Portfolio Table 88. IntoxLab Recent Development Table 89. Creative Diagnostics Company Information Table 90. Creative Diagnostics Business Overview Table 91. Creative Diagnostics Vaccine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Creative Diagnostics Vaccine Testing Service Product Portfolio Table 93. Creative Diagnostics Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Vaccine Testing Service Product Image Figure 2. Global Vaccine Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccine Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Physical and Chemical Testing Image Figure 8. Microbial Detection Image Figure 9. Immunological Testing Image Figure 10. Others Image Figure 11. Global Vaccine Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Vaccine Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Vaccine Testing Service Sales Value Share by Type (2021-2032) Figure 14. Inactivated Vaccine Image Figure 15. Subunit Vaccine Image Figure 16. Toxoid Vaccine Image Figure 17. mRNA Vaccine Image Figure 18. Viral Vector Vaccine Image Figure 19. Others Image Figure 20. Global Vaccine Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Vaccine Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Vaccine Testing Service Sales Value Share by Application (2021-2032) Figure 23. Global Vaccine Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Vaccine Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Vaccine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 26. North America Vaccine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Vaccine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Vaccine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Vaccine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Vaccine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Vaccine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 32. South America Vaccine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Vaccine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Vaccine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Vaccine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Physical and Chemical Testing
  • Microbial Detection
  • Immunological Testing
  • Others
Applications
  • Inactivated Vaccine
  • Subunit Vaccine
  • Toxoid Vaccine
  • mRNA Vaccine
  • Viral Vector Vaccine
  • Others
Companies covered
  • RSSL
  • Labcorp Drug Development
  • Charles River Laboratories
  • PPD
  • WuXi Biologics
  • Valneva
  • IQVIA Laboratories Vaccines
  • Minaris Advanced Testing
  • IntoxLab
  • Creative Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vaccine Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vaccine Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Vaccine Testing Service Market Dynamics
  1. 2.1 Vaccine Testing Service Industry Trends
  2. 2.2 Vaccine Testing Service Industry Drivers
  3. 2.3 Vaccine Testing Service Industry Opportunities and Challenges
  4. 2.4 Vaccine Testing Service Industry Restraints
3 Vaccine Testing Service Market by Company
  1. 3.1 Global Vaccine Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global Vaccine Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global Vaccine Testing Service Company Ranking (2024-2026)
  4. 3.4 Global Vaccine Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Vaccine Testing Service Company Product Type and Application
  6. 3.6 Global Vaccine Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Vaccine Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Vaccine Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Vaccine Testing Service Market by Type
  1. 4.1 Vaccine Testing Service Type Introduction
  2. 4.1.1 Physical and Chemical Testing
  3. 4.1.2 Microbial Detection
  4. 4.1.3 Immunological Testing
  5. 4.1.4 Others
  6. 4.2 Global Vaccine Testing Service Sales Value by Type
  7. 4.2.1 Global Vaccine Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Vaccine Testing Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Vaccine Testing Service Sales Value Share by Type (2021-2032)
5 Vaccine Testing Service Market by Application
  1. 5.1 Vaccine Testing Service Application Introduction
  2. 5.1.1 Inactivated Vaccine
  3. 5.1.2 Subunit Vaccine
  4. 5.1.3 Toxoid Vaccine
  5. 5.1.4 mRNA Vaccine
  6. 5.1.5 Viral Vector Vaccine
  7. 5.1.6 Others
  8. 5.2 Global Vaccine Testing Service Sales Value by Application
  9. 5.2.1 Global Vaccine Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Vaccine Testing Service Sales Value by Application (2021-2032)
  11. 5.2.3 Global Vaccine Testing Service Sales Value Share by Application (2021-2032)
6 Vaccine Testing Service Regional Value Analysis
  1. 6.1 Global Vaccine Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccine Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Vaccine Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Vaccine Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vaccine Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America Vaccine Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Vaccine Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Vaccine Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Vaccine Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Vaccine Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Vaccine Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America Vaccine Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Vaccine Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Vaccine Testing Service Sales Value Share by Country, 2025 VS 2032
7 Vaccine Testing Service Country-level Value Analysis
  1. 7.1 Global Vaccine Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vaccine Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Vaccine Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Vaccine Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Vaccine Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Vaccine Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Vaccine Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 RSSL
  2. 8.1.1 RSSL Company Information
  3. 8.1.2 RSSL Business Overview
  4. 8.1.3 RSSL Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 RSSL Vaccine Testing Service Product Portfolio
  6. 8.1.5 RSSL Recent Developments
  7. 8.2 Labcorp Drug Development
  8. 8.2.1 Labcorp Drug Development Company Information
  9. 8.2.2 Labcorp Drug Development Business Overview
  10. 8.2.3 Labcorp Drug Development Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Labcorp Drug Development Vaccine Testing Service Product Portfolio
  12. 8.2.5 Labcorp Drug Development Recent Developments
  13. 8.3 Charles River Laboratories
  14. 8.3.1 Charles River Laboratories Company Information
  15. 8.3.2 Charles River Laboratories Business Overview
  16. 8.3.3 Charles River Laboratories Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Charles River Laboratories Vaccine Testing Service Product Portfolio
  18. 8.3.5 Charles River Laboratories Recent Developments
  19. 8.4 PPD
  20. 8.4.1 PPD Company Information
  21. 8.4.2 PPD Business Overview
  22. 8.4.3 PPD Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PPD Vaccine Testing Service Product Portfolio
  24. 8.4.5 PPD Recent Developments
  25. 8.5 WuXi Biologics
  26. 8.5.1 WuXi Biologics Company Information
  27. 8.5.2 WuXi Biologics Business Overview
  28. 8.5.3 WuXi Biologics Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi Biologics Vaccine Testing Service Product Portfolio
  30. 8.5.5 WuXi Biologics Recent Developments
  31. 8.6 Valneva
  32. 8.6.1 Valneva Company Information
  33. 8.6.2 Valneva Business Overview
  34. 8.6.3 Valneva Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Valneva Vaccine Testing Service Product Portfolio
  36. 8.6.5 Valneva Recent Developments
  37. 8.7 IQVIA Laboratories Vaccines
  38. 8.7.1 IQVIA Laboratories Vaccines Company Information
  39. 8.7.2 IQVIA Laboratories Vaccines Business Overview
  40. 8.7.3 IQVIA Laboratories Vaccines Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 IQVIA Laboratories Vaccines Vaccine Testing Service Product Portfolio
  42. 8.7.5 IQVIA Laboratories Vaccines Recent Developments
  43. 8.8 Minaris Advanced Testing
  44. 8.8.1 Minaris Advanced Testing Company Information
  45. 8.8.2 Minaris Advanced Testing Business Overview
  46. 8.8.3 Minaris Advanced Testing Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Minaris Advanced Testing Vaccine Testing Service Product Portfolio
  48. 8.8.5 Minaris Advanced Testing Recent Developments
  49. 8.9 IntoxLab
  50. 8.9.1 IntoxLab Company Information
  51. 8.9.2 IntoxLab Business Overview
  52. 8.9.3 IntoxLab Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IntoxLab Vaccine Testing Service Product Portfolio
  54. 8.9.5 IntoxLab Recent Developments
  55. 8.10 Creative Diagnostics
  56. 8.10.1 Creative Diagnostics Company Information
  57. 8.10.2 Creative Diagnostics Business Overview
  58. 8.10.3 Creative Diagnostics Vaccine Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Creative Diagnostics Vaccine Testing Service Product Portfolio
  60. 8.10.5 Creative Diagnostics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst